Feasterville, PA, United States of America

Alfred Robert Langish

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Feasterville, PA (US) (2021)
  • Princeton, NJ (US) (2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alfred Robert Langish: Innovator in Therapeutic Antibodies

Introduction

Alfred Robert Langish is a notable inventor based in Feasterville, PA (US). He has made significant contributions to the field of therapeutic antibodies, holding a total of 2 patents. His work focuses on innovative solutions for treating inflammatory diseases.

Latest Patents

Langish's latest patents include groundbreaking research on antibodies against the IL-7R alpha subunit. These antibodies are designed to bind to the alpha subunit of the IL-7 receptor (IL-7Rα). The patents detail the therapeutic applications of these antibodies, particularly in the treatment of inflammatory diseases. Additionally, the patents provide information on the cells that produce these antibodies, the polynucleotides encoding the heavy and/or light chain regions, and the vectors that comprise these polynucleotides.

Career Highlights

Langish is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in therapeutic applications. His work has been instrumental in developing new treatments that leverage the body's immune response.

Collaborations

Throughout his career, Langish has collaborated with notable colleagues, including Aaron Paul Yamniuk and Scott Ronald Brodeur. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Alfred Robert Langish is a prominent figure in the field of therapeutic antibodies, with a focus on innovative treatments for inflammatory diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…